Capstone Therapeutics Corp banner

Capstone Therapeutics Corp
OTC:CAPS

Watchlist Manager
Capstone Therapeutics Corp Logo
Capstone Therapeutics Corp
OTC:CAPS
Watchlist
Price: 0.55 USD 2.98% Market Closed
Market Cap: $4.6m

Capstone Therapeutics Corp
Other Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Capstone Therapeutics Corp
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
Capstone Therapeutics Corp
OTC:CAPS
Other Items
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Items
-$5.9B
CAGR 3-Years
-108%
CAGR 5-Years
31%
CAGR 10-Years
4%
Gilead Sciences Inc
NASDAQ:GILD
Other Items
-$3B
CAGR 3-Years
-22%
CAGR 5-Years
8%
CAGR 10-Years
11%
Amgen Inc
NASDAQ:AMGN
Other Items
-$85m
CAGR 3-Years
74%
CAGR 5-Years
55%
CAGR 10-Years
33%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Items
-$1.1B
CAGR 3-Years
-40%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Items
$691.2m
CAGR 3-Years
N/A
CAGR 5-Years
5%
CAGR 10-Years
N/A
No Stocks Found

Capstone Therapeutics Corp
Glance View

Market Cap
4.6m USD
Industry
Biotechnology

Capstone Therapeutics Corp. is a biotechnology company. The company is headquartered in Tempe, Arizona. The firm is focused on development and commercialization of Apo E mimetic peptide AEM-28-14, through its investment in LipimetiX Development LLC. Apolipoprotein E is a 299 amino acid protein, which plays an important role in lipoprotein metabolism. AEM-28 is a 28 amino acid mimetic of Apo E and AEM-28-14, an analog of AEM-28, is a 28 amino acid mimetic of Apo E with an amino-hexanoic acid group and a phospholipid and both contain a domain, which anchors into a lipoprotein surface while also providing the Apo E receptor binding domain, which allows clearance through the heparan sulfate proteoglycan (HSPG) receptors in the liver. AEM-28-14 as an Apo E mimetic, has the potential to enhance the clearance of triglyceride- and cholesterol-rich lipoproteins from the plasma.

CAPS Intrinsic Value
Not Available

See Also

What is Capstone Therapeutics Corp's Other Items?
Other Items
0 USD

Based on the financial report for Dec 31, 2019, Capstone Therapeutics Corp's Other Items amounts to 0 USD.

Back to Top